Results 171 to 180 of about 61,475 (266)

SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT This study examined changes in anti‐Spike (anti‐S) antibodies (Abs) and type I interferon (IFN‐I) following the BNT162b2 vaccine in people living with HIV (PLWH) and analyzed the impact of demographic and immunological factors. In total, 75 PLWH and 28 healthy donors were followed at baseline (T0), at the second dose (T1), after the second ...
Federica Frasca   +18 more
wiley   +1 more source

Metachronous nasopharyngeal carcinoma following sinonasal inverted papilloma - a diagnostic enigma. [PDF]

open access: yesEur Arch Otorhinolaryngol
Dosemane D   +5 more
europepmc   +1 more source

Clinical‐Stage Nanatinostat Triggers Productive Epstein‐Barr Virus Lytic Replication

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT A phase 1b/2 study of the all‐oral “kick‐and‐kill” combo nanatinostat + valganciclovir (nana‐val) showed a ~40% overall response rate in patients with relapsed/refractory Epstein‐Barr virus (EBV)‐associated lymphomas. Despite the promising results in these difficult‐to‐treat cancers, there is little known about the effects of nanatinostat on ...
Ibukun A. Akinyemi   +6 more
wiley   +1 more source

An Epstein‐Barr Virus Nuclear Antigen 1 (EBNA1) Serology Test Strip for Nasopharyngeal Carcinoma Risk Screening

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT Antibodies to Epstein‐Barr virus (EBV) proteins can predict nasopharyngeal carcinoma (NPC) risk. We previously defined a prototype EBNA1 protein panel and multiplex immunoblot assay that distinguishes NPC risk several years pre‐diagnosis.
Benjamin E. Warner   +7 more
wiley   +1 more source

Time-dependent Diffusion MRI for Predicting Response to Induction Chemotherapy in Nasopharyngeal Carcinoma. [PDF]

open access: yesRadiol Imaging Cancer
Ren H   +13 more
europepmc   +1 more source

Tumor Growth Rate in Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Objective This scoping review evaluates the current literature on tumor growth rate in head and neck cancer patients and its potential prognostic value on survival, loco‐regional control and recurrence (PROSPERO registration CRD42022370828). Review Methods PubMed, Embase, and Scopus were searched for publications between 1990 and November 5th ...
Gilles Delahaut   +5 more
wiley   +1 more source

Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma. [PDF]

open access: yesTransl Oncol
Huang Q   +7 more
europepmc   +1 more source

Timing of Carotid Blow‐Out After Locoregional Recurrence in Head and Neck Cancer: A Single‐Center Retrospective Study

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Background Carotid blow‐out syndrome (CBS) is a life‐threatening complication of head and neck cancer, often occurring after prior treatment and locoregional recurrence. Data on the timing of carotid rupture after local tissue compromise remain limited.
Fırat Tevetoğlu   +4 more
wiley   +1 more source

The triad of nasopharyngeal carcinoma pathogenesis: host genetics, viral infection, and environmental exposures. [PDF]

open access: yesFront Oncol
Nath I   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy